Metabolic Syndrome Risk Associated with Atypical Antipsychotic Medication: A Case Report

People with schizophrenia are vulnerable group suffer from metabolic syndrome events. Atypical antipsychotics associated with weight gain, insulin resistance, and profile lipid abnormalities. The present case was 32-year-old man schizophrenia outpatient had experienced metabolic syndrome side effect...

Full description

Saved in:
Bibliographic Details
Main Authors: Julaeha, -, Umi Athiyah, -, Josephine P Ayuningtyas, -, Verra Yuliana, -, Andi Hermansyah, -
Format: Article PeerReviewed
Language:English
English
English
English
Published: Society of Pharmaceutical Technocrats 2021
Subjects:
Online Access:https://repository.unair.ac.id/124451/1/Bukti%20Artikel%20C-24.pdf
https://repository.unair.ac.id/124451/4/Bukti%20Validasi%20dan%20Penilaian%20Karil%20C-24.pdf
https://repository.unair.ac.id/124451/3/Bukti%20Similarity%20C-24.pdf
https://repository.unair.ac.id/124451/2/Bukti%20Korespondensi%20C-24.pdf
https://repository.unair.ac.id/124451/
https://jddtonline.info/index.php/jddt/article/view/4680
https://doi.org/10.22270/jddt.v11i1.4680
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
English
English

Similar Items